Journal of Medicinal Chemistry · 2009 · 65 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationHit-to-lead OptimizationLead Compound DesignLead DiscoveryPotency OptimizationCompound Potency OptimizationLead Compound PrioritizationMolecular Property Optimization
By use of chemical enablement and prospective design, a novel series of selective, brain penetrant PDE9A inhibitors have been identified that are capable of producing in vivo elevations of brain cGMP.
17
Daniel K. Gehlhaar, Gennady M. Verkhivker, Paul A. Rejto et al. · Chemistry & Biology · 1995 · 685 citations · Full text
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
G.L. Card, B.P. England, Yoshihisa Suzuki et al. · Structure · 2004 · 431 citations · Full text